Health care economics Archives - GEN - Genetic Engineering and Biotechnology News

Home 2024

Akamis Bio Raises $60 Million for Cancer Gene Therapy, Signs Licensing Deal with Xuanzhu Biopharma

Cancer

Akamis Bio Raises $60 Million for Cancer Gene Therapy, Signs Licensing Deal with Xuanzhu Biopharma

DNA-Based Vaccine Production Provides Best Shot at Profitability

Bioprocessing

DNA-Based Vaccine Production Provides Best Shot at Profitability

Abzena Expands Analytical Capabilities to Include GMP Cell-Based Potency Testing

Bioprocessing

Abzena Expands Analytical Capabilities to Include GMP Cell-Based Potency Testing

Treehill CEO Sees Positives for Biopharma in Trump’s Re-Election

Drug Discovery

Treehill CEO Sees Positives for Biopharma in Trump’s Re-Election

Vitrian Closed $50M Investment in AmplifyBio’s Manufacturing Center

Bioprocessing

Vitrian Closed $50M Investment in AmplifyBio’s Manufacturing Center

Using Yeast to Reduce Bioprocess Development Costs

Bioprocessing

Using Yeast to Reduce Bioprocess Development Costs

Seaport Eyes Platform, Pipeline Growth with $225M Series B

Drug Discovery

Seaport Eyes Platform, Pipeline Growth with $225M Series B

With $5.3M in Funding, clock.bio Makes Progress on Longevity Research Using Stem Cells

Drug Discovery

With $5.3M in Funding, clock.bio Makes Progress on Longevity Research Using Stem Cells

Symbiosis Acquires a 20,000-Square-Foot Biomanufacturing Building in Stirling, U.K.

Bioprocessing

Symbiosis Acquires a 20,000-Square-Foot Biomanufacturing Building in Stirling, U.K.

StockWatch: BioAge, Orum Reflect Renewed Interest in IPOs

Drug Discovery

StockWatch: BioAge, Orum Reflect Renewed Interest in IPOs

12 3...198 Page 1 of 198